Overview


According to FutureWise analysis the market for Pharmaceutical Excipients is expected to reach US$ 13.91 billion by 2031 at a CAGR of 6.80%.

A pharmaceutical excipient acts as a synthetic or natural substance made with an active ingredient of a medication. It is found in the form of a pharmaceutical dosage to help in the manufacturing operations and it serves to support, protect or even heighten stability. Additionally, they aid in identifying the products and strengthen the safety or functional aspects of the product.

The surge in the pharmaceutical excipients market potential can be the result of the expanding pharmaceuticals industry along with innovations in functional excipients, the growing acceptance of orphan drugs, and the rise in the allowance of biopharmaceuticals. However, the high costs, time consumption in the drug development procedure, as well as the stringency enacted by regulatory bodies are factors which may pose hindrances to the market growth during the forecast time frame.
By product type, the market for pharmaceutical excipients is classified into three primary categories namely, inorganic chemicals, organic chemicals as well as other chemicals. The organic chemicals was demonstrated to hold the largest market share. The considerable market share is owing to the usage of these chemicals in the numerous pharmaceutical formulations which are accessible in the pharmaceutical market.

The diluents fillers segment has acquired a bulk of the market share of the pharmaceutical excipients industry. The significant market value of this segment is linked to the growing usage of diluents fillers in the production and development processes of solid oral drugs and the benefits that they provide to patients and manufacturers alike.
With the formulation, the pharmaceutical excipients market is divided into topical, oral, parenteral, as well as formulations. Oral formulations has seen robust growth for this market, primarily due to oral formulations being the most common method of drug delivery.

  • Ashland Global Holdings
  • BASF SE
  • DuPont
  • Roquette Feres
  • Evonik Industries AG
  • Associated British Foods
  • Archer Daniels Midland Company
  • Lubrizol Corporation
  • Croda International
  • Holdings

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Organic Chemicals
  • Inorganic Chemicals
  • Other Devices

By Functionality

  • Fillers and Diluents
  • Suspending and Viscosity Agents
  • Coating Agents
  • Binders
  • Flavoring Agents and Sweeteners
  • Disintegrants
  • Colorants
  • Lubricants and Glidants
  • Preservatives
  • Emulsifying Agents
  • Other Functionalities

By Formulation

  • Oral Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other Formulations

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the market by Product, by functionality, by formulation and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East Africa
  • To record, evaluate and analyze competitive landscape mapping- technological advancements, product launches, expansions and mergers

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Pharmaceutical Excipients Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Global Pharmaceutical Excipients Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pharmaceutical Excipients Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Pharmaceutical Excipients Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Pharmaceutical Excipients Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Organic Chemicals
        2. Inorganic Chemicals
        3. Other Devices

  • 8.  Global Pharmaceutical Excipients Market, By Functionality Historical Analysis and Forecast 2023-2031 (USD Million
    •        1. Fillers and Diluents
        2. Suspending and Viscosity Agents
        3. Coating Agents
        4. Binders
        5. Flavoring Agents and Sweeteners
        6. Disintegrants
        7. Colorants
        8. Lubricants and Glidants
        9. Preservatives
        10. Emulsifying Agents
        11. Other Functionalities

  • 9.  Global Pharmaceutical Excipients Market, By Formulation Historical Analysis and Forecast 2023-2031 (USD Million)
    •      1. Oral Formulations
        2. Topical Formulations
        3. Parenteral Formulations
        4. Other Formulations

  • 10.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Taiwan
         2.9. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Ashland Global Holdings
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BASF SE
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. DuPont
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Roquette Feres
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5 . Evonik Industries AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6 . Associated British Foods
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Archer Daniels Midland Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Lubrizol Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Croda International
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Holdings
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients